Related Experiment Video
Updated: Jul 16, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Safety and real-world outcomes from a home-based, systemic anticancer therapy program: A prospective observational
Borja Gomez-Mediavilla1, Maria Lanza-Postigo2, Carmen Hinojo Gonzalez3
1Department of Nursing, Universidad de Cantabria, Santander, Spain; Nursing Research Group, IDIVAL - Health Research Institute Valdecilla, Santander, Spain; Research Group of Qualitative and Mixed Methods in Health Sciences (QMix Health), Department of Nursing, Universidad de Cantabria, Santander, Spain.
International Journal of Nursing Studies
|July 14, 2026
Summary
Home administration of systemic anticancer therapies is safe and feasible for oncology patients. This nurse-led program reduces hospital burden while maintaining treatment adherence and safety.
Area of Science:
- Oncology
- Healthcare Management
- Nursing
Background:
- Increasing patient numbers strain oncology day hospitals.
- Frequent visits impact patient quality of life.
- Home administration of therapies offers a solution.
Purpose of the Study:
- Evaluate safety and feasibility of home-based systemic anticancer therapy administration.
- Assess a nurse-led program for home oncology care.
Main Methods:
- Prospective observational study.
- Adult oncology patients receiving selected therapies.
- Predefined clinical criteria for home administration.
Main Results:
- 186 patients, 2226 home administrations.
- Zero infusion reactions, extravasations, or urgent complications.
- Maintained adherence and hospital workflows.
Conclusions:
- Home administration is feasible and safe with proper protocols.
- Specialized nursing and patient selection are key.
- Home-based programs optimize resources and ensure safe therapy delivery.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...